DCF — GENESIS MEDICAL CENTER - SILVIS
Enterprise Value: $-124.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-124.5M
Enterprise Value
$-40.3M
PV of Cash Flows
$-84.3M
PV of Terminal Value
$-135.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $103.9M | $-7.3M | -7.0% | $-11.7M | $-10.6M |
| Year 2 | $107.0M | $-6.4M | -6.0% | $-11.0M | $-9.1M |
| Year 3 | $110.2M | $-5.5M | -5.0% | $-10.2M | $-7.7M |
| Year 4 | $113.5M | $-5.1M | -5.0% | $-9.9M | $-6.8M |
| Year 5 | $116.9M | $-5.0M | -4.0% | $-9.9M | $-6.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-124.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$100.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07510160200549018
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5